药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Amifostine
Temefos
The risk or severity of QTc prolongation can be increased when Temefos is combined with Romidepsin.
Amifostine
Tetrahydropalmatine
The risk or severity of QTc prolongation can be increased when Tetrahydropalmatine is combined with Romidepsin.
Amifostine
Delafloxacin
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Romidepsin.
Amifostine
Prulifloxacin
The risk or severity of QTc prolongation can be increased when Prulifloxacin is combined with Romidepsin.
Amifostine
CUDC-907
The risk or severity of QTc prolongation can be increased when CUDC-907 is combined with Romidepsin.
Amifostine
Anisodamine
The risk or severity of QTc prolongation can be increased when Anisodamine is combined with Romidepsin.
Amifostine
Pazufloxacin
The risk or severity of QTc prolongation can be increased when Pazufloxacin is combined with Romidepsin.
Amifostine
Talinolol
The risk or severity of QTc prolongation can be increased when Talinolol is combined with Romidepsin.
Amifostine
Rupatadine
The risk or severity of QTc prolongation can be increased when Rupatadine is combined with Romidepsin.
Amifostine
Bilastine
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Romidepsin.
Amifostine
Difloxacin
The risk or severity of QTc prolongation can be increased when Difloxacin is combined with Romidepsin.
Amifostine
Sarafloxacin
The risk or severity of QTc prolongation can be increased when Sarafloxacin is combined with Romidepsin.
Amifostine
Phosmet
The risk or severity of QTc prolongation can be increased when Phosmet is combined with Romidepsin.
Amifostine
Orbifloxacin
The risk or severity of QTc prolongation can be increased when Orbifloxacin is combined with Romidepsin.
Amifostine
Fenthion
The risk or severity of QTc prolongation can be increased when Fenthion is combined with Romidepsin.
Amifostine
Famphur
The risk or severity of QTc prolongation can be increased when Famphur is combined with Romidepsin.
Amifostine
Dichlorvos
The risk or severity of QTc prolongation can be increased when Dichlorvos is combined with Romidepsin.
Amifostine
Coumaphos
The risk or severity of QTc prolongation can be increased when Coumaphos is combined with Romidepsin.
Amifostine
Acrivastine
The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Romidepsin.
Amifostine
Lacidipine
The risk or severity of QTc prolongation can be increased when Lacidipine is combined with Romidepsin.